AT
NVO

Arvest Trust’s Novo Nordisk NVO Stock Holding History

Arvest Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,096
Closed -$372K – 182
2023
Q3 		$372K Hold
4,096
– – 0.02% 128
2023
Q2 		$330K Hold
4,096
– – 0.02% 136
2023
Q1 		$326K Hold
4,096
– – 0.02% 124
2022
Q4 		$277K Buy
+4,096
New +$240K 0.02% 144

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Arvest Trust's NVO Position: Q4 2023 in Review

Arvest Trust sold out of Novo Nordisk (NVO) in Q4 2023, closing a stake of 4,096 shares — an estimated $372K sold.

Arvest Trust first reported a position in NVO in Q4 2022 and held it in 4 quarters. The position peaked at $372K in Q3 2023. 1,511 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

  • Arvest Trust reported no remaining Novo Nordisk position as of Q4 2023 after selling out during the quarter.
  • Arvest Trust sold 4,096 Novo Nordisk shares in Q4 2023, an estimated $372K.
  • Arvest Trust first reported a position in Novo Nordisk in Q4 2022 and held it in 4 quarters.
  • Arvest Trust's Novo Nordisk position peaked at $372K in Q3 2023.
  • 1,511 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on Arvest Trust's 13F filing for Q4 2023, filed 24 Jan 2024.